Additional file 6 of Leveraging CD16 fusion receptors to remodel the immune response for enhancing anti-tumor immunotherapy in iPSC-derived NK cells
收藏数据链接:
官方服务:
资源简介:
Additional file 6. Table S1. Antibodies used in this study.
创建时间:
2023-06-14

Additional file 6. Table S1. Antibodies used in this study.